[1] Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1):7-30. [2] 丁显飞, 周学良, 豆萌萌, 等. 哺乳动物雷帕霉素靶蛋白的表达及其与乳腺癌预后关系的Meta分析[J]. 吉林大学学报:医学版,2016, 42(4):783-788. [3] Ling P, Yao Z, Meyer CF, et al. Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-Jun N-terminal kinase[J]. Mol Cell Biol, 1999, 19(2):1359-1368. [4] Chuang HC, Wang X, Tan TH. MAP4K family kinases in immunity and inflammation[J]. Adv Immunol, 2016, 129:277-314. [5] Sawasdikosol S, Zha R, Yang B, et al. HPK1 as a novel target for cancer immunotherapy[J]. Immunol Res, 2012, 54(1-3):262-265. [6] Wang H, Song X, Logsdon C, et al. Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer[J]. Cancer Res, 2009, 69(3):1063-1070. [7] Alzabin S, Pyarajan S, Yee H, et al. Hematopoietic progenitor kinase 1 is a critical component of prostaglandin E2-mediated suppression of the anti-tumor immune response[J]. Cancer Immunol Immunother, 2010, 59(3):419-429. [8] Li Z, Park HR, Shi Z, et al. Pro-oncogenic function of HIP-55/Drebrin-like (DBNL) through Ser269/Thr291-phospho-sensor motifs[J]. Oncotarget, 2014, 5(10):3197-3209. [9] Wang Y, Luo H, Li Y, et al. hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a promising diagnostic marker in human bladder urothelial carcinomas[J]. Mol Med Rep, 2012, 5(1):260-265. [10] 王娇娇, 宋丽杰, 杨森, 等. 造血祖细胞激酶1在雌激素受体阳性乳腺癌中的表达及其与预后的关系[J]. 中华实验外科杂志, 2016, 33(8):2022-2025. [11] Tavangar F, Sepehri H, Saghaeian Jazi M, et al. Amphotericin B potentiates the anticancer activity of doxorubicin on the MCF-7 breast cancer cells[J]. J Chem Biol, 2017, 10(3):143-150. [12] van der Heijden AG, Mengual L, Lozano JJ, et al. A five-gene expression signature to predict progression in T1G3 bladder cancer[J]. Eur J Cancer, 2016, 64:127-136. [13] Lin M, Zhang Y, Li A, et al. High-throughput RNAi screening of human kinases identifies predictors of clinical outcome in colorectal cancer patients treated with oxaliplatin[J]. Oncotarget, 2015, 6(18):16774-16785. [14] 孟凡荣, 陈琛, 万海粟, 等. 慢病毒载体及其研究进展[J]. 中国肺癌杂志, 2014(12):870-876. [15] Yan F, He Q, Hu X, et al. Direct regulation of caspase-3 by the transcription factor AP-2 is involved in aspirininduced apoptosis in MDAMB453 breast cancer cells[J]. Mol Med Rep, 2013, 7(3):909-914. [16] Yelken Bö, Balci T, Süslüer SY, et al. The effect of tomatine on metastasis related matrix metalloproteinase (MMP) activities in breast cancer cell model[J]. Gene, 2017, 627:408-411. [17] Harvey J, Thomas C, Wood B, et al. Practical issues concerning the implementation of Ki-67 proliferative index measurement in breast cancer reporting[J]. Pathology, 2015, 47(1):13-20. |